This inventor holds 3 USPTO granted patents. Top assignee: Purdue Research Foundation. Active years: 2005-2013.
Location History:
- Chesterfield, MO (US) (2005)
- Columbia, IL (US) (2010)
- West Lafayette, IN (US) (2013)
Company Filing History:
Years Active: 2005-2013
Title: Patrick W. Hein: Innovator in Cancer Therapeutics
Introduction
Patrick W. Hein is a notable inventor based in West Lafayette, IN (US). He has made significant contributions to the field of cancer research, particularly through his innovative approaches to targeting specific proteins involved in metastatic disease. With a total of 3 patents, Hein's work is paving the way for new therapeutic strategies in oncology.
Latest Patents
Hein's latest patents focus on the EphA2 protein as a therapeutic target for cancer treatment. The first patent outlines compounds and methods for treating metastatic disease, emphasizing the specificity of these compounds for EphA2, an epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. The second patent similarly addresses the treatment of cancer, highlighting the potential of these compounds to be formulated into pharmaceutical compositions aimed at combating metastatic cancer.
Career Highlights
Hein is affiliated with the Purdue Research Foundation, where he continues to advance his research in cancer therapeutics. His work is characterized by a commitment to developing effective treatments that target the underlying mechanisms of cancer progression.
Collaborations
Hein collaborates with esteemed colleagues such as Michael Scott Kinch and Nicole D. Zantek, contributing to a dynamic research environment focused on innovative cancer solutions.
Conclusion
Patrick W. Hein's contributions to cancer research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to inspire advancements in therapeutic strategies for metastatic disease.